NCT05954260View on ClinicalTrials.gov

Immune Dysfunction in Critical Illness: Utility of a Panel of Genes and Molecules Involved in the Immunological Synapse

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Critical Illness
Interventions
DIAGNOSTIC_TEST

Blood sampling

We will collect blood samples from the patients included in the study on ICU days 1, 3 and 5. We will measure gene expression (mRNA) and plasma levels of various elements involved in the immunological synapse.

Trial Locations (1)

47012

RECRUITING

Hospital Universitario Río Hortega, Valladolid

All Listed Sponsors
collaborator

Hospital del Rio Hortega

OTHER

collaborator

Sanidad de Castilla y León

OTHER

collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Fundación Española del Enfermo Crítico (FEEC)

UNKNOWN

collaborator

Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC)

UNKNOWN

lead

David Pérez Torres

OTHER